Docoh
Loading...

EYPT EyePoint Pharmaceuticals

Employees

Data from SEC filings
Employee count

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
On April 26, 2021, the record date for the Annual Meeting, there were 28,741,475 shares of Common Stock issued and outstanding and entitled to vote on the proposals presented at the Annual Meeting, of which [23,587,523] or [82.07]%, were present in person via virtual communication or voted by proxy, which constituted a quorum. The holders of shares of Common Stock are entitled to one vote for each share held and cumulative voting for directors is not permitted. The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows:

Proposal No. 1.Election of Directors

The Company’s stockholders elected the following directors to the Board, each to serve until the Company’s 2022 Annual Meeting or until such person’s successor is duly elected and qualified. The voting on this proposal is set forth below:

Vote TypeVote Results
Göran Ando, M.D.For 20,600,583
Withheld 190,590
Broker Non-Votes 2,796,350
Nancy LurkerFor 20,586,119
Withheld 205,054
Broker Non-Votes 2,796,350
Ronald W. EastmanFor 20,603,219
Withheld 187,954
Broker Non-Votes 2,796,350
John B. Landis, Ph.D.For 20,607,069
Withheld 184,104
Broker Non-Votes 2,796,350
David Guyer, M.D.For 20,602,544
Withheld 188,629
Broker Non-Votes 2,796,350
Wendy F. DiCiccoFor 20,610,147
Withheld 181,026
Broker Non-Votes 2,796,350




Ye LiuFor 20,609,472
Withheld 181,701
Broker Non-Votes 2,796,350


Proposal No. 2.Approval of Amendment to the 2016 Long-Term Incentive Plan

The Company’s stockholders approved an amendment to the 2016 Long-Term Incentive Plan to increase the number of shares of Common Stock authorized for issuance thereunder by 2,500,000 shares. The voting on this proposal is set forth below:

Vote typeVote Results
For 20,297,042
Against 381,145
Abstain 112,986
Non Votes 2,796,350


Proposal No. 3. Approval of Amendment to the 2019 Employee Stock Purchase Plan

The Company’s stockholders approved an amendment to the 2019 Employee Stock Purchase Plan to increase the number of shares of Common Stock authorized for issuance thereunder by 250,000 shares. The voting on this proposal is set forth below:

Vote typeVote Results
For 20,448,879
Against 320,005
Abstain 22,289
Non Votes 2,796,350


Proposal No. 4 Non-Binding Advisory Vote on Named Executive Officer Compensation

The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The voting on this proposal is set forth below:

Vote typeVote Results
For 20,354,739
Against 379,909
Abstain 56,525
Non Votes 2,796,350


Proposal No. 5.Ratification of Appointment of Independent Registered Public Accounting Firm

The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021. The voting on this proposal is set forth below:

Vote typeVote Results
For 23,539,331
Against 20,891
Abstain 27,301
Non Votes 0